Actively Recruiting

All Genders
NCT07558382

Global Initiative on Takayasu Arteritis (GITA)

Led by Marmara University · Updated on 2026-04-30

1000

Participants Needed

2

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Takayasu's Arteritis Global Registry aims to bring a large group of patients from different parts of the world to analyse and compare the patients' demographic, clinical, laboratory, radiological and prognostic features with outcomes, approaches to diagnosis, assessment, management and therapeutic interventions in different centers. The present project provides for both a retrospective and a prospective longitudinal study. The study is designed as retrospective for patients already diagnosed with TAK and treated with available treatments. Also, the study is designed as prospective for patients diagnosed with TAK after the initiation of the Registry or the adhesion to the project. This is thought as a multicentre, international study addressed to all Centers that will want to contribute to the present project. The study is non-interventional: demographic, clinical and therapeutic data required over time are collected with the routine diagnostic, clinical and therapeutic procedures usually carried out for the optimal management of patients and according with good clinical practice.

CONDITIONS

Official Title

Global Initiative on Takayasu Arteritis (GITA)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Each patient must fulfill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis
  • Patients or their legal representatives must provide informed and free agreement to participate
  • Participants or their representatives must willingly comply with study protocol requirements for the study duration
  • Participants must sign written and dated informed consent after being fully informed about the study
  • Participants are informed they can withdraw consent at any time without affecting future medical care
Not Eligible

You will not qualify if you...

  • Patients who do not fulfill the ACR 1990 or ACR/EULAR 2021 criteria for Takayasu arteritis
  • Patients who do not provide or sign informed consent or assent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Marmara University School of Medicine

Istanbul, Istanbul, Turkey (Türkiye), 34899

Actively Recruiting

2

Marmara University School of Medicine

Istanbul, Istanbul, Turkey (Türkiye), 34899

Actively Recruiting

Loading map...

Research Team

F

Fatma Alibaz-Oner, Professor, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here